119 related articles for article (PubMed ID: 8773742)
1. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies.
Elçin YM; Dixit V; Gitnick G
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):257-71. PubMed ID: 8773742
[TBL] [Abstract][Full Text] [Related]
2. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing.
Elçin YM; Dixit V; Gitnick G
Artif Organs; 2001 Jul; 25(7):558-65. PubMed ID: 11493277
[TBL] [Abstract][Full Text] [Related]
3. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances.
Hunter SK; Kao JM; Wang Y; Benda JA; Rodgers VG
ASAIO J; 1999; 45(1):37-40. PubMed ID: 9952004
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach.
Elçin YM; Dixit V; Lewin K; Gitnick G
Artif Organs; 1999 Feb; 23(2):146-52. PubMed ID: 10027884
[TBL] [Abstract][Full Text] [Related]
5. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs.
Jameela SR; Misra A; Jayakrishnan A
J Biomater Sci Polym Ed; 1994; 6(7):621-32. PubMed ID: 7873513
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
7. In vitro slow release profile of endothelial cell growth factor immobilized within calcium alginate microbeads.
Ko C; Dixit V; Shaw W; Gitnick G
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(2):143-51. PubMed ID: 7767437
[TBL] [Abstract][Full Text] [Related]
8. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
Bayomi MA
Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable chitosan matrix for the controlled release of steroids.
Chandy T; Sharma CP
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
[TBL] [Abstract][Full Text] [Related]
10. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant.
Mi FL; Tan YC; Liang HF; Sung HW
Biomaterials; 2002 Jan; 23(1):181-91. PubMed ID: 11762837
[TBL] [Abstract][Full Text] [Related]
11. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.
Jameela SR; Jayakrishnan A
Biomaterials; 1995 Jul; 16(10):769-75. PubMed ID: 7492707
[TBL] [Abstract][Full Text] [Related]
12. Polymers for induction of revascularization in the rat fascial flap: application of vascular endothelial growth factor and pancreatic islet cells.
Linn T; Erb D; Schneider D; Kidszun A; Elçin AE; Bretzel RG; Elçin YM
Cell Transplant; 2003; 12(7):769-78. PubMed ID: 14653623
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
Lee BJ; Choe JS; Kim CK
J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique.
King TW; Patrick CW
J Biomed Mater Res; 2000 Sep; 51(3):383-90. PubMed ID: 10880080
[TBL] [Abstract][Full Text] [Related]
15. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
Lee DW; Hwang SJ; Park JB; Park HJ
J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
[TBL] [Abstract][Full Text] [Related]
16. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
Fujita M; Ishihara M; Simizu M; Obara K; Ishizuka T; Saito Y; Yura H; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Biomaterials; 2004 Feb; 25(4):699-706. PubMed ID: 14607508
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of chitosan microspheres containing doxifluridine.
Yoshino T; Machida Y; Onishi H; Nagai T
Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
[TBL] [Abstract][Full Text] [Related]
18. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
Machida Y; Nagai T; Abe M; Sannan T
Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
[TBL] [Abstract][Full Text] [Related]
19. [Research on carboxymethyl chitosan acting as the adjuvant for implantable degradable microspheres].
Yin C; Hou C; Jiang L; Gu Q
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):350-4. PubMed ID: 15250131
[TBL] [Abstract][Full Text] [Related]
20. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique.
Bayomi MA; al-Suwayeh SA; el-Helw AM; Mesnad AF
Pharm Acta Helv; 1998 Dec; 73(4):187-92. PubMed ID: 9861867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
